Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
Recruiting · NCT07192991 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Observational study
What this trial is about
This observational, retrospective study aims to understand the treatment patterns and outcomes of patients with pulmonary and extra-pulmonary neuroendocrine carcinomas (NEC) in Latin America (Brazil, Mexico, Argentina, and Peru). The research will collect data from medical records to analyze factors like patient demographics, diagnosis methods, tumor characteristics, treatment approaches, and disease progression. The study is non-interventional, meaning patient care will follow standard clinical practice, with data gathered via an electronic system.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- ≥18 years old
- Diagnosed between August 2014 and August 2024 with one of the following:
- Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
- Large-cell neuroendocrine carcinoma (LCNEC) or mixed
- Small Cell Lung Cancer (SCLC) or mixed
- Adequate and accessible medical records for data collection
- Tumor block collected from 2014 onwards
Exclusion criteria
- Patients with active, concurrent malignancies at the time of NEC diagnosis, except for non-invasive cancers like basal cell carcinoma or squamous cell carcinoma of the skin, or in situ cervical cancer.
- Patients or their legal representatives unwilling or unable to provide informed consent (if needed per ethics committee).
Where it is running
19 locations listed.
- Hospital Británico de Buenos Aires - Buenos Aires, Buenos Aires, Argentina
- Hospital de Gastroenterología Carlos Bonorino Udaondo - Buenos Aires, Buenos Aires, Argentina
- Instituto Alexander Fleming - Buenos Aires, Buenos Aires, Argentina
- Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO) - Cachoeiro de Itapemirim, Espírito Santo, Brazil
- Oncosalud AUNA - Lima, Lima Province, Peru
- Clínica Prognóstica - Centro de Pesquisa Clínica Onconeo - Campo Grande, Mato Grosso do Sul, Brazil
- Centro Oncológico Internacional (COI) - Mexico City, Mexico City, Mexico
- INCan - Instituto Nacional de Cancerología - Mexico City, Mexico City, Mexico
- Oncocentro de Minas Gerais (Oncoclínicas) - Belo Horizonte, Minas Gerais, Brazil
- IOP Pesquisa - Instituto de Oncologia do Paraná - Curitiba, Paraná, Brazil
- HCL - Hospital do Câncer de Londrina - Londrina, Paraná, Brazil
- HUOL - Hospital Universitário Onofre Lopes da UFRN - Natal, Rio Grande do Norte, Brazil
- Liga Norte Riograndense Contra o Câncer - Natal, Rio Grande do Norte, Brazil
- HMV - Hospital Moinhos de Vento - Porto Alegre, Rio Grande do Sul, Brazil
- Futtura Oncologia - Hub de Pesquisa Clínica - Porto Alegre, Rio Grande do Sul, Brazil
- INCA - Instituto Nacional de Câncer - Rio de Janeiro, Rio de Janeiro, Brazil
- ANIMI - Unidade de Tratamento Oncológico - Lages, Santa Catarina, Brazil
- A.C. Camargo Cancer Center - São Paulo, São Paulo, Brazil
- HIAE - Hospital Israelita Albert Einstein - São Paulo, São Paulo, Brazil